🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 9 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/09/1997 | 44,43 | 44,64 | 43,36 | 44,28 | +0,47% | 2,89% | 7.866.498 |
| 11/09/1997 | 44,07 | 44,43 | 43,57 | 44,07 | -0,07% | 1,96% | 6.130.800 |
| 10/09/1997 | 44,61 | 44,82 | 44,04 | 44,10 | -2,12% | 1,74% | 6.421.306 |
| 09/09/1997 | 44,70 | 45,56 | 44,61 | 45,06 | +0,87% | 2,13% | 4.183.826 |
| 08/09/1997 | 45,92 | 46,01 | 44,55 | 44,67 | -1,96% | 3,18% | 4.141.906 |
| 05/09/1997 | 45,92 | 46,16 | 45,12 | 45,56 | +0,20% | 2,27% | 5.025.579 |
| 04/09/1997 | 45,68 | 46,01 | 45,15 | 45,47 | -0,65% | 1,89% | 4.441.214 |
| 03/09/1997 | 45,65 | 45,98 | 45,21 | 45,77 | +0,26% | 1,70% | 5.210.446 |
| 02/09/1997 | 43,95 | 45,68 | 43,95 | 45,65 | +4,22% | 3,93% | 5.613.507 |
| 29/08/1997 | 43,83 | 44,61 | 43,59 | 43,80 | -0,20% | 2,31% | 5.130.798 |
| 28/08/1997 | 44,07 | 45,03 | 43,57 | 43,89 | -0,94% | 3,32% | 5.799.422 |
| 27/08/1997 | 43,77 | 44,67 | 43,77 | 44,31 | +1,36% | 2,04% | 5.357.586 |
| 26/08/1997 | 44,55 | 44,94 | 43,71 | 43,71 | -2,01% | 2,74% | 4.836.101 |
| 25/08/1997 | 45,32 | 45,56 | 44,37 | 44,61 | -0,93% | 2,63% | 4.244.400 |
| 22/08/1997 | 44,13 | 45,21 | 44,01 | 45,03 | -0,40% | 2,70% | 7.678.067 |
| 21/08/1997 | 45,80 | 45,89 | 44,40 | 45,21 | -1,04% | 3,26% | 4.406.211 |
| 20/08/1997 | 45,44 | 45,83 | 45,26 | 45,68 | +1,06% | 1,25% | 7.219.882 |
| 19/08/1997 | 44,85 | 45,24 | 44,49 | 45,21 | +1,61% | 1,66% | 7.574.315 |
| 18/08/1997 | 43,57 | 44,55 | 43,42 | 44,49 | +2,61% | 2,60% | 8.919.109 |
| 15/08/1997 | 44,34 | 44,58 | 43,30 | 43,36 | -2,61% | 2,89% | 7.953.062 |
| 14/08/1997 | 44,58 | 45,00 | 44,28 | 44,52 | +0,74% | 1,61% | 9.835.270 |
| 13/08/1997 | 45,09 | 45,21 | 43,65 | 44,19 | -1,07% | 3,44% | 12.801.530 |
| 12/08/1997 | 45,44 | 45,68 | 44,61 | 44,67 | -1,71% | 2,36% | 9.516.469 |
| 11/08/1997 | 46,52 | 46,58 | 45,32 | 45,44 | -3,61% | 2,69% | 9.906.744 |
| 08/08/1997 | 47,38 | 47,95 | 46,79 | 47,14 | -0,94% | 2,45% | 6.576.619 |
| 07/08/1997 | 49,14 | 49,26 | 47,53 | 47,59 | -2,21% | 3,52% | 8.826.466 |
| 06/08/1997 | 48,78 | 48,96 | 48,54 | 48,66 | -0,97% | 0,86% | 4.835.891 |
| 05/08/1997 | 48,96 | 49,59 | 48,66 | 49,14 | -0,12% | 1,89% | 4.158.674 |
| 04/08/1997 | 48,66 | 49,29 | 48,52 | 49,20 | +0,61% | 1,59% | 3.957.248 |
| 01/08/1997 | 49,59 | 49,83 | 48,46 | 48,90 | -1,32% | 2,77% | 4.068.336 |